This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ramírez, J. L. Articles by Gracia-Navarro, F. Search for Related Content PubMed PubMed Citation Articles by Ramírez, J. L. Articles by Gracia-Navarro, F.

Growth Hormone (GH)-Releasing Factor Differentially Activates Cyclic Adenosine 3',5'-Monophosphate- and Inositol Phosphate-Dependent Pathways to Stimulate GH Release in Two Porcine Somatotrope Subpopulations¹

Department of Cell Biology, University of Córdoba (J.L.R., J.P.C., R.T., A.J.M.-F., S.G.-N., F.G.-N.), 14004 Córdoba, Spain; and the Department of Cell Biology and Anatomy, Medical University of South Carolina (L.S.F.), Charleston, South Carolina 29425

Address all correspondence and requests for reprints to: Dr. F. Gracia-Navarro, Department of Cell Biology, Faculty of Sciences, Avda. San Alberto Magno s/n, University of Córdoba, 14004 Córdoba, Spain. E-mail: bc1grnaf{at}uco.es

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
Somatotropes comprise two morphologically and functionally distinct subpopulations of low (LD) and high (HD) density cells. We recently reported that GRF induces different patterns of increase in the cytosolic free Ca²⁺ concentration in single porcine LD and HD somatotropes, which for LD cells required not only Ca²⁺ influx but also intracellular Ca²⁺ mobilization. This suggested that GRF may activate multiple signaling pathways in pig LD and HD somatotropes to stimulate GH secretion. To address this question, we first assessed the direct GRF effect on second messenger activation in cultures of LD and HD cells by measuring cAMP levels and [³H]myo-inositol incorporation. Secondly, to determine the relative importance of cAMP- and inositol phosphate (IP)-dependent pathways, and of intra- and extracellular Ca²⁺, GRF-induced GH release from cultured LD and HD somatotropes was measured in the presence of specific blockers. GRF increased cAMP levels in both subpopulations, whereas it only augmented IP turnover in LD cells. Accordingly, adenylate cyclase inhibition by MDL-12,330A abolished GRF-stimulated GH release in both subpopulations, whereas phospholipase C inhibition by U-73122 only reduced this effect partially in LD cells. Likewise, blockade of Ca²⁺ influx with Cl₂Co reduced GRF-stimulated GH secretion in both LD and HD somatotropes, whereas depletion of thapsigargin-sensitive intracellular Ca²⁺ stores only decreased the secretory response to GRF in LD cells. These results demonstrate that GRF specifically and differentially activates multiple signaling pathways in two somatotrope subpopulations to stimulate GH release. Thus, although the prevailing signaling cascade employed by GRF in both subpopulations is adenylate cyclase/cAMP/extracellular Ca²⁺, the peptide also requires activation of the phospholipase C/IP/intracellular Ca²⁺ pathway to exert its full effect in porcine LD somatotropes.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
THE HYPOTHALAMIC peptide GRF is the primary evocative stimulus for pituitary somatotropes (1, 2, 3) and exerts its actions on GH secretion and gene transcription through a specific membrane receptor(s) that belongs to the seven-transmembrane-spanning, G protein-linked family of receptors (4). Binding of GRF to its receptor activates at least two major signaling pathways that involve the second messengers cAMP and Ca²⁺, respectively (reviewed in Refs. 1, 3, 5). GRF increases cAMP levels by stimulating adenylate cyclase (AC) through a G_s protein (1, 3, 6, 7, 8). Subsequently, increased cAMP levels induce activation of protein kinase A (PKA), which, in turn, activates several proteins by phosphorylation, including ion channels (1, 3, 4, 9). Likewise, GRF increases the cytosolic free Ca²⁺ concentration ([Ca²⁺]_i) in somatotropes from a number of species, including human (10), pig (11), rat (12, 13), cow (14), and sheep (15). Current information indicates that this rise in [Ca²⁺]_i is essentially dependent on the entry of extracellular Ca²⁺ through voltage-sensitive Ca²⁺ channels (VSCC) (reviewed in Ref. 5). The precise mechanism(s) that activates such VSCCs has not been fully elucidated, but there is evidence for the involvement of Na⁺ channels and PKA-dependent phosphorylation(s) in this process (3, 5, 16).

Although cAMP production and Ca²⁺ influx constitute two pivotal mechanisms employed by GRF to exert its actions on somatotropes, it has been suggested that this peptide can also activate other signaling mechanisms in these cells (1, 3). Accordingly, results from a limited number of studies (17, 18; reviewed in Refs. 1, 3) have raised doubts against the prevailing view that GRF does not activate the phospholipase C (PLC)/inositol phosphate (IP) pathway and the subsequent mobilization of intracellular Ca²⁺ in rat somatotropes (12, 13, 19, 20, 21). That this system is present and functional in somatotropes has been clearly demonstrated by studies on the mechanisms of action of synthetic GH secretagogues such as GH-releasing hexapeptide (GHRP-6) (22, 23, 24). However, whereas earlier reports showed GRF to stimulate phosphatidyl inositol turnover in cultured rat pituitary cells (17), other researchers later reported that GRF did not significantly alter ³²P incorporation into IPs in purified rat somatotropes (20). Similarly, Ohlsson and Lindström (18) demonstrated that GRF stimulated Ca²⁺ efflux from purified somatotropes in a Ca²⁺-depleted medium and thereby suggested that it mobilized Ca²⁺ from intracellular pools. However, other studies have reported that both the GH release and the [Ca²⁺]_i increase stimulated by GRF in purified somatotropes were inhibited when somatotropes were incubated in Ca²⁺-free medium or treated with a Ca²⁺ antagonist (12). Therefore, there are still some aspects of the possible involvement of the PLC/IP/intracellular Ca²⁺ system in the response of somatotropes to GRF that require clarification (1, 3, 21).

In the present study, we have investigated the relative contributions of different intracellular signaling pathways to the secretory response of porcine somatotropes to GRF. The reason for selecting this particular model is 2-fold: first, because the mechanisms employed by GRF to release GH in vitro in this species have not been addressed hitherto, and second, and more important, because recent findings on the functional heterogeneity of pig somatotropes suggested a possible cellular basis for the complex response of this cell type to GRF (11). Indeed, previous studies from our group showed that the porcine somatotrope population is heterogeneous and can be separated by density gradient centrifugation into two major subpopulations of low (LD) and high (HD) density cells, which display substantial differences in ultrastructure, secretory capacity, and response to regulatory factors (25, 26, 27). In particular, GRF was recently found to induce a differential response in [Ca²⁺]_i dynamics in LD and HD somatotropes. Thus, the response of LD cells to GRF depended on both extracellular Ca²⁺ influx and mobilization of Ca²⁺ from intracellular stores, whereas that of HD somatotropes was exclusively dependent on extracellular Ca²⁺ entry through L-type VSCCs (11). Inasmuch as these results suggested that GRF may differentially activate distinct signaling cascades in each subpopulation, the aim of the present study was to elucidate which pathways underlie the secretory response of porcine LD and HD somatotropes to GRF. To answer this question, cAMP levels and [³H]myo-inositol incorporation were quantified in cultures of separated subpopulations after GRF treatment. Furthermore, specific inhibitors of distinct signaling pathways were employed to ascertain the relative importance of such routes to GRF-stimulated GH secretion.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Animals, cell dispersion, and separation of subpopulations
Prepubertal Large-White/Landrace female pigs (5–6 months old) were obtained from a local slaughterhouse. Animals were killed by exsanguination after brief electrical stunning, and pituitary glands were immediately removed and transferred to sterile cold (4 C) medium (D-valine-modified MEM; Sigma Chemical Co., London, UK) supplemented with 0.1% BSA (Sigma Chemical Co.) and antibiotic-antimycotic solution (Sigma Chemical Co.). In the laboratory, pituitaries were washed twice with fresh medium, and the posterior lobes were discarded. For each separate, independent experiment, six to eight pituitary glands were pooled and dispersed together by means of an enzymatic-mechanical dispersion method described previously (25, 26). Briefly, glands were cut into fragments of 1–2 mm³ and then exposed to sequential incubation with 0.3% trypsin (type I, Sigma Chemical Co.), 0.1% collagenase (type V, Sigma Chemical Co.), 0.1% soybean trypsin inhibitor I (Sigma Chemical Co.), 2 µg/ml deoxyribonuclease (Sigma Chemical Co.), and Ca²⁺/Mg²⁺-free HBSS (Sigma Chemical Co.) with EDTA (2 and 1 mM), followed by mechanical dispersion with a Pasteur pipette. Cellular viability, as determined by the trypan blue exclusion test, was always higher than 85%.

Separation of somatotrope subpopulations was carried out by centrifugation in a Percoll density gradient as previously reported (25, 26). In short, 30–40 x 10⁶ dispersed cells were resuspended in 0.5 ml medium and carefully loaded on top of a hyperbolic, continuous Percoll density gradient (Pharmacia LKB, Uppsala, Sweden). This preparation was centrifuged at 3000 x g for 25 min, and two somatotrope subpopulations of LD (1.051–1.064 g/ml) and HD (1.087–1.098 g/ml) were isolated, which have been thoroughly characterized in previous studies (26, 27). Dispersed cells from each subpopulation were cultured in MEM supplemented with 10% FBS (Sera-Lab, Crawley-Down, UK) in a humidified atmosphere of 5% CO₂-95% air at 37 C. Experiments were carried out after 4 days of culture. A 2-h preincubation in fresh MEM without FBS was used to stabilize basal GH secretion before adding test substances.

Measurement of cAMP
To measure cAMP, LD and HD cell subpopulations were plated in six-well tissue culture plates at a density of 2 x 10⁶ cells/well·2 ml MEM-FBS. After the 2-h preincubation in FBS-free MEM, cells were incubated for 30 min in MEM containing 1 mM of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX; Sigma Chemical Co.) to prevent enzymatic degradation of cAMP. Then, cells were incubated for an additional 30-min period in MEM-IBMX in the presence or absence of 10^-8 M GRF-(1–29) (UCB Bioproducts, Brain L’Alleud, Belgium). Medium was then aspirated, and wells were scraped in 0.01 M PBS with 4 mM EDTA. Subsequently, aliquots for protein determination were removed, and samples were sonicated (5 min), boiled (10 min), and centrifuged at 10,000 rpm for 5 min. The supernatant was removed and stored at -20 C until cAMP determination by means of a [³H]cAMP assay kit (Amersham, Aylesbury, UK). Results are reported as picomoles of cAMP per mg total protein.

Measurement of [³H]myo-inositol incorporation
To evaluate [³H]myo-inositol incorporation, LD and HD cells were plated in 12-well plates at 6 x 10⁵ cells/well·2 ml MEM-FBS. After the 2-h preincubation in FBS-free MEM, cells were incubated for 30 min in 500 µl MEM containing [³H]myo-inositol (3 µCi/ml; 10–25 Ci/mmol; DuPont, Stevenage, UK) in the presence or absence of 10^-8 M GRF. Then, medium was aspirated and the reaction was stopped by adding 500 µl ice-cold 20% trichloroacetic acid. Wells were scraped, and the contents were placed in Eppendorf tubes, sonicated, and pelleted by centrifugation at 12,000 rpm for 15 min at 4 C. Supernatant, which contained IPs, was removed and measured in a scintillation counter (LS 6000TA, Beckman Coulter, Inc., Fullerton, CA). Chloroform-methanol (1:1, vol/vol) was then added to the pellet to extract the phosphoinosi-tides (PIPs). After centrifugation (12,000 rpm, 20 min), the supernatant was also removed and measured. Because results obtained for IPs and PIPs showed identical profiles and statistical differences (despite the expected differences in the absolute counts per min measurements), both values were added, and the results are reported as the total amount of [³H]myo-inositol incorporated in each sample (IPs plus PIPs) and are expressed as counts per min/mg total protein.

Evaluation of GH secretion
In this set of experiments, dispersed cells from each subpopulation were cultured during 4 days at a density of 3 x 10⁵/well/ml in 24-well plates. After the 2-h preincubation in FBS-free MEM, cells were incubated for an additional 2-h period with MEM alone or MEM that contained one of the following inhibitors: 1) AC inhibitor, 10 µM MDL-12,330A (Research Biochemicals International, Natick, MA) (28); 2) PLC inhibitor, 50 µM U-73122 (Research Biochemicals International) (29, 30); 3) VSCC blocker, 2 mM CoCl₂ (14, 31); and 4) sarco/endoplasmic reticulum Ca²⁺-adenosine triphosphatase inhibitor (to deplete intracellular Ca²⁺ stores), 100 nM thapsigargin (TG; Sigma Chemical Co.) (11, 22, 32). Immediately thereafter, cells were challenged for 30 min with 10^-8 M GRF in the presence or absence of the corresponding inhibitor. Then, medium was removed and microfuged, and the supernatant was stored at -20 C until porcine GH was measured by means of a homologous enzyme immunoassay (EIA), described previously (26). Hormone employed in the EIA for both plate coating and standard was pGH (USDA-B-1, AFP-11716C; kindly supplied by Dr. A. Parlow, Pituitary Hormones and Antisera Center, Harbor University of California-Los Angeles Medical Center, Los Angeles, CA), and the primary antiserum was a specific anti-pGH (raised in rabbit; UCB) at a dilution of 1:200,000. The sensitivity of the EIA was 0.65 ± 0.12 ng pGH/well.

Statistical analysis
Data are expressed as the mean ± SEM obtained from at least three separate, independent experiments. In each experiment, at least four replicate wells were tested per treatment group. Statistical analysis was performed with one-way ANOVA, followed by a statistical test for multiple comparisons (Duncan’s multiple range test and critical ranges) by use of the software package Statistica (StatSoft, Inc., Tulsa, OK). Differences were considered significant at P < 0.05.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Role of the cAMP-dependent pathway in GRF-stimulated GH release
Measurement of cAMP in cultures of separated subpopulations of porcine pituitary cells demonstrated that cAMP levels were higher in LD than in HD cells under basal culture conditions (14.1 ± 2.0 vs. 6.6 ± 1.9 pmol/mg protein, respectively; Fig. 1). In both subpopulations, GRF (10^-8 M; 30 min) evoked a significant increase in cAMP levels (Fig. 1), that was proportionally higher for HD (3-fold; lower panel) than for LD cells (2-fold; upper panel). To examine the possible contribution of this cAMP rise to GRF-induced GH release from LD and HD somatotropes, we evaluated the effect of the specific AC inhibitor MDL-13,330A on the stimulation caused by the peptide. None of the inhibitors used in this and the remaining experiments that analyzed other intracellular signaling pathways significantly altered basal GH secretion from either subpopulation. However, as indicated by the results depicted in Fig. 2, MDL-12,330A abolished the stimulatory effect of GRF in both LD (upper panel), and HD (lower panel) cells. These results demonstrate that activation of the AC-cAMP system is required by GRF to stimulate the secretory response of both porcine somatotrope subpopulations.

View larger version (15K): [in this window] [in a new window]   Figure 1. Effect of GRF on cAMP production in monolayer cultures of porcine LD (upper panel) and HD (lower panel) pituitary cells. After 4 days of culture in MEM-FBS, cells were equilibrated for 2 h in serum-free MEM and then incubated with 1 mM IBMX for 30 min. After incubation, cells were challenged for 30 min with 10-8 M GRF in presence of IBMX. Thereafter, cAMP production was measured. Data are expressed as picomoles of cAMP per mg total protein. Each bar represents the mean ± SEM of four independent experiments. At least three replicate wells were evaluated per treatment in each experiment. a, P < 0.05 vs. corresponding control.

View larger version (23K): [in this window] [in a new window]   Figure 2. Effect of AC inhibition on GRF-stimulated GH secretion in LD (upper panel) and HD (lower panel) porcine somatotropes. After 4 days of culture in MEM-FBS, cells were equilibrated for 2 h in serum-free MEM and then incubated with or without 10 µM MDL-12,330A. Then, cells were challenged with 10-8 M GRF for 30 min in the presence or absence of MDL-12,330A. Each bar represents the mean ± SEM of five independent experiments. At least four replicate wells were evaluated per treatment in each experiment. Data are expressed as percentage of the respective control value (100%; dotted line). a, P < 0.05 vs. corresponding control; b, P < 0.05 vs. GRF alone.

View larger version (14K): [in this window] [in a new window]   Figure 3. Incorporation of [3H]myo-inositol in monolayer cultures of porcine LD (upper panel) and HD (lower panel) cells in response to GRF. After 4 days of culture in MEM-FBS, cells were equilibrated for 2 h in serum-free MEM and then incubated with 10-8 M GRF for 30 min in the presence of [3H]myo-inositol. Thereafter, samples were recovered, and labeled IPs and PIPs were measured. Data are expressed as the total counts per min/mg total protein. Each bar represents the mean ± SEM of three independent experiments. At least three replicate wells were evaluated per treatment in each experiment. a, P < 0.05 vs. control.

View larger version (28K): [in this window] [in a new window]   Figure 4. Secretory response of LD (upper panel) and HD (lower panel) porcine somatotropes to 10-8 M GRF after blockade of PLC activity. After 4 days of culture in MEM-FBS, cells were equilibrated for 2 h in serum-free MEM, and then incubated with or without 50 µM U-73122. Thereafter, cells were incubated with 10-8 M GRF for 30 min in the presence or absence of U-73122 (n = 6). See Fig. 2 for further details. a, P < 0.05 vs. corresponding control; b, P < 0.05 vs. GRF alone.

View larger version (25K): [in this window] [in a new window]   Figure 5. Effect of blockade of Ca2+ influx by 2 mM CoCl2 on GRF-stimulated GH secretion in LD (upper panel) and HD (lower panel) porcine somatotropes (n = 3). See Fig. 2 for further details. a, P < 0.05 vs. corresponding control; b, P < 0.05 vs. GRF alone.

View larger version (26K): [in this window] [in a new window]   Figure 6. Effect of depletion of intracellular Ca2+ stores by 100 nM TG on GRF-stimulated GH secretion in LD (upper panel) and HD (lower panel) porcine somatotropes (n = 3). See Fig. 2 for further details. a, P < 0.05 vs. corresponding control; b, P < 0.05 vs. GRF alone.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

A first approach toward evaluating the possible involvement of different signaling pathways in the response of porcine somatotropes to GRF was to directly determine cAMP levels and IP turnover in cultures of LD and HD cells. Interestingly, initial results revealed clear differences in basal levels of second messengers in these subpopulations, in that both cAMP levels and [³H]myo-inositol incorporation were higher in LD than in HD cells. As both subpopulations are enriched in somatotropes (i.e. composed of at least 40–50% GH cells) (26), it is likely that such differences in cAMP and IP may be attributed at least in part to somatotropes within each subpopulation. These results would be consistent with our previous findings that these same subpopulations exhibited comparable differences in basal [Ca²⁺]_i levels measured at the single somatotrope level (11). Moreover, the reduced rate of second messenger activity detected in the HD subpopulation may help to explain the observation that these cells contain 4-fold more GH, but only release twice the amount of hormone as LD somatotropes (26). Thus, taken together, these and previous results suggest that heterogeneity of porcine LD and HD somatotropes includes not only the reported differences in density, ultrastructure, and response to regulatory factors, but also molecular differences in terms of second messenger levels under basal culture conditions.

It is widely accepted that two major events in the response of somatotropes to GRF are a cAMP increase and extracellular Ca²⁺ entry (1, 3, 5, 21). Consistent with this idea, our results indicated the critical role played by the AC/cAMP/extracellular Ca²⁺ signaling system in the stimulatory action of GRF in both porcine somatotrope subpopulations. Thus, the ability of GRF to increase cAMP levels coupled with the observation that GRF-stimulated GH release was blocked in the presence of an AC inhibitor demonstrated the requisite participation of the AC/cAMP system in mediating the effect of the peptide in both LD and HD somatotropes. Likewise, the decrease in GRF-induced GH release observed when VSCCs were blocked with CoCl₂ indicated clearly the importance of extracellular Ca²⁺ entry for the stimulatory effect of GRF. These latter results confirm and expand our previous observations that Ca²⁺ from extracellular origin is involved in the GRF-induced [Ca²⁺]_i elevation in both somatotrope subpopulations (11). The precise sequence of events linking GRF activation of the AC/cAMP/PKA pathway, external Ca²⁺ entry, and hormone release has not been fully elucidated. In rat and human somatotropes, it has been reported that PKA-dependent phosphorylation of Ca²⁺, Na⁺, and nonselective cation channels and/or related proteins (1, 3, 5, 16, 34) may participate in this complex mechanism. In porcine somatotropes, it has been recently shown that inactivation of PKA by H-89 drastically reduced the effect of pituitary adenylate cyclase-activating polypeptide on extracellular Ca²⁺ entry through VSCC, thereby indicating that a PKA-dependent phosphorylation of such channels or related proteins would precede Ca²⁺ entry (35). It is thus conceivable that a similar mechanism operates in the case of GRF in porcine somatotropes. Nevertheless, it is noteworthy that whereas AC inhibition abolished the effect of GRF on GH release, blockade of Ca²⁺ by CoCl₂ partially reduced, but did not abolish, GRF stimulation. As in porcine somatotropes CoCl₂ has been shown to prevent [Ca²⁺]_i increases mediated by Ca²⁺ influx (11), the present results raise the interesting possibility that activation of the AC/cAMP/PKA cascade in these cells induces effects on GH release that are independent of Ca²⁺ entry. In support of this idea, recent studies on insulin-secreting mouse ß-cells revealed a mechanism by which cAMP induced exocytosis in a manner independent of net increases in [Ca²⁺]_i (36, 37). This might represent an additional mechanism for cAMP to potentiate GH release in somatotropes, as has been suggested for human GH-releasing adenoma cells (34).

The possible involvement of the PLC/IP pathway and of intracellular Ca²⁺ stores in the stimulatory action of GRF on GH secretion has been a matter of controversy in recent years. Although some researchers argue that such signaling mechanisms are not involved in this response, others have provided evidence suggesting their participation (1, 3, 5, 12, 13, 17, 18, 19, 20, 21). Our strategy of studying separated, functionally distinct subpopulations of somatotropes may shed light on this issue. Accordingly, GRF increased IP turnover in cultures of LD, but not HD, cells, and inhibition of PLC partially reduced GRF-stimulated GH secretion from LD somatotropes without altering that from companion cultures of HD cells. Likewise, mobilization of Ca²⁺ from intracellular stores, a common subsequent step after PLC/IP pathway activation, was only required in the response of LD somatotropes, as depletion of these stores by thapsigargin blunted GRF-stimulated GH secretion in LD, but not in HD, somatotropes. Taken together, these results demonstrate the differential involvement of the PLC/IP/intracellular Ca²⁺ pathway in the secretory response of porcine LD and HD somatotropes to GRF. This idea was initially suggested by a previous study in which the GRF-evoked [Ca²⁺]_i increase in single LD somatotropes was partly due to mobilization of Ca²⁺ from internal stores, whereas the rise of [Ca²⁺]_i in HD somatotropes was exclusively dependent on extracellular Ca²⁺ entry. It is presently unknown whether this situation also occurs in somatotropes from other species. If that were the case, it is plausible that negative results from previous studies on the participation of the PLC/IP/intracellular Ca²⁺ pathway in the response to GRF could be attributed to the limited contribution of this signaling route in comparison with the clear predominance of the AC/cAMP/PKA pathway in this response. In other cases, the use of purified preparations of somatotropes may have selected specific subpopulations of this cell type in which the PLC/IP/intracellular Ca²⁺ pathway is not activated in response to GRF (12, 13, 20). Furthermore, given the dynamic changes experienced by LD and HD somatotrope subpopulations during postnatal development (27) and aging (38), it is possible that the differential involvement of IP and cAMP in the somatotrope response to GRF may vary with animal age. This consideration notwithstanding, the present data clearly demonstrate the existence of molecular heterogeneity in the response of porcine somatotrope subpopulations to GRF in terms of intracellular signaling mechanisms (Fig. 7), which may help in understanding the seemingly contradictory results found previously for this cell type.

View larger version (39K): [in this window] [in a new window]   Figure 7. Schematic diagram summarizing the possible signaling pathways and mechanisms involved in the GRF-induced stimulatory response of porcine LD and HD somatotropes. GRF-R, GRF receptor; ß, subunits of heterotrimeric G proteins (Gs and Gp); IP3, inositol 1,4,5-trisphosphate; Ca2+, cytosolic free calcium. See Discussion for details.

In conclusion, our results reveal that GRF-induced GH release is mediated through differential activation of two intracellular signaling pathways in LD and HD subpopulations of porcine somatotropes. Although the AC/cAMP/extracellular Ca²⁺ system is the predominant route employed by GRF in both subpopulations, the peptide also requires activation of the PLC/IP/intracellular Ca²⁺ route to exert its full effect in LD somatotropes. Further studies will be required to ascertain the relevance of this somatotrope heterogeneity in second messenger activation and to elucidate the possible role of GRF receptor(s) in this phenomenon.

	Acknowledgments

 
We thank Dr. A. F. Parlow from the Pituitary Hormones and Antisera Center, Harbor-University of California-Los Angeles Medical Center, and Drs. D. J. Bolt and D. W. Caldwell, from USDA Animal Hormone Program, Beltsville Agriculture Research Center, for the generous gift of pGH.

	Footnotes

 
¹ This work was supported by Grants CRG-971039 (NATO), CVI-0139 (Plan Andaluz de Investigación, Junta de Andalucía, Spain), and PB97–0454 (Ministerio de Educación y Cultura, Spain).

Received September 11, 1998.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Frohman LA, Downs TR, Chomczynski P 1992 Regulation of growth hormone secretion. Front Neuroendocrinol 13:344–405[Medline]
2. Della-Fera MA, Buonomo FC, Baile CA 1986 Growth hormone releasing factors and secretion of growth hormone in sheep, calves and pigs. Dom Anim Endocrinol 3:165–176
3. Frohman LA 1996 Cellular physiology of growth hormone releasing hormone. In: Bercu BB, Walker RF (eds) Growth Hormone Secretagogues. Springer-Verlag, New York, pp 137–146
4. Mayo KE, Godfrey PA, DeAlmeida V, Miller TL 1996 Structure, function, and regulation of the pituitary receptor for growth hormone-releasing hormone. In: Bercu BB, Walker RF (eds) Growth Hormone Secretagogues. Springer-Verlag, New York, pp 53–71
5. Chen C, Vincent JD, Clarke IJ 1994 Ion channels and the signal transduction pathways in the regulation of growth hormone secretion. Trends Endocrinol Metab 5:227–233[CrossRef][Medline]
6. Bilezikjian LM, Vale WW 1983 Stimulation of adenosine 3',5'-monophosphate production by growth hormone-releasing factor and its inhibition by somatostatin in anterior pituitary cells in vitro. Endocrinology 113:1726–1731[Abstract/Free Full Text]
7. Narayanan N, Lussier B, French M, Moor B, Kraicer J 1989 Growth hormone-releasing factor-sensitive adenylate cyclase system of purified somatotrophs: effects of guanine nucleotides, somatostatin, calcium, and magnesium. Endocrinology 124:484–495[Abstract/Free Full Text]
8. Sartin JL, Coleman ES, Steele B 1996 Interaction of cyclic AMP- and calcium-dependent mechanisms in the regulation of growth hormone-releasing hormone-stimulated growth hormone release from ovine pituitary cells. Dom Anim Endocrinol 13:229–238[CrossRef][Medline]
9. Wong AOL, Moor BC, Hawkins CE, Narayanan N, Kraicer J 1995 Cytosolic protein kinase A mediates the growth hormone (GH)-releasing action of GH-releasing factor in purified rat somatotrophs. Neuroendocrinology 61:590–600[Medline]
10. Dufy-Barbe L, Bresson L, Sartor P, Odessa MF, Dufy B 1992 Calcium homeostasis in growth hormone (GH)-secreting adenoma cells: effect of GH-releasing factor. Endocrinology 131:1436–1444[Abstract/Free Full Text]
11. Ramírez JL, Torronteras R, Malagón MM, Castaño JP, García-Navarro S, González de Aguilar JL, Martínez-Fuentes AJ, Gracia-Navarro F 1998 Growth hormone-releasing factor mobilizes cytosolic free calcium through different mechanisms in two somatotrope subpopulations from porcine pituitary. Cell Calcium 23:207–217[CrossRef][Medline]
12. Lussier BT, French MB, Moor BC, Kraicer J 1991 Free intracellular Ca²⁺ concentration ([Ca²⁺]_i) and growth hormone release from purified rat somatotrophs. I. GH-releasing factor-induced Ca²⁺ influx raises [Ca²⁺]_i. Endocrinology 128:570–582[Abstract/Free Full Text]
13. Lussier BT, French MB, Moor BC, Kraicer J 1991 Free intracellular Ca²⁺ concentration and growth hormone (GH) release from purified rat somatotrophs. III. Mechanism of action of GH-releasing factor and somatostatin. Endocrinology 128:592–603[Abstract/Free Full Text]
14. Rawlings SR, Hoyland J, Mason WT 1991 Calcium homeostasis in bovine somatotrophs: calcium oscillations and calcium regulation by growth hormone-releasing hormone and somatostatin. Cell Calcium 12:403–414[CrossRef][Medline]
15. Chen C, Clarke IJ 1995 Modulation of Ca²⁺ influx in the ovine somatotroph by growth hormone-releasing factor. Am J Physiol 268:E204–E212
16. Kato M, Sakuma Y 1997 Regulation by growth hormone-releasing hormone and somatostatin of a Na⁺ current in the primary cultured rat somatotroph. Endocrinology 138:5096–5100[Abstract/Free Full Text]
17. Canonico PL, Cronin MJ, Thorner MO, MacLeod RM 1983 Human pancreatic GRF stimulates phosphatidyl inositol labeling in cultured anterior pituitary cells. Am J Physiol 245:E587–E590
18. Ohlsson L, Lindström P 1990 The correlation between calcium outflow and growth hormone release in perifused rat somatotrophs. Endocrinology 126:488–497[Abstract/Free Full Text]
19. Escobar DC, Vicentini LM, Ghigo E, Ciccarelli E, Usellini L, Capella C, Cocchi D 1986 Growth hormone-releasing factor does not stimulate phosphoinositide breakdown in primary cultures of rat and human pituitary cells. Acta Endocrinol (Copenh) 112:345–350[Abstract/Free Full Text]
20. French MB, Lussier BT, Moor BC, Kraicer J 1990 Effect of growth hormone-releasing factor on phosphoinositide hydrolysis in somatotrophs. Mol Cell Endocrinol 72:221–226[CrossRef][Medline]
21. Bluet-Pajot MT, Bertherat J, Epelbaum J, Kordon C 1993 Neural and pituitary mechanism involved in growth hormone regulation. J Pediatr Endocrinol Metab 6:357–369
22. Bresson-Bepoldin L, Dufy-Barbe L 1994 GHRP-6 induces a biphasic calcium response in rat pituitary somatotrophs. Cell Calcium 15:247–258[CrossRef][Medline]
23. Herrington J, Hille B 1994 Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotropes by two mechanisms. Endocrinology 135:1100–1108[Abstract]
24. Smith RG, Van der Ploeg LH, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt Jr MJ, Fisher MH, Nargund RP, Patchett AA 1997 Peptidomimetic regulation of growth hormone secretion. Endocr Rev 18:621–645[Abstract/Free Full Text]
25. Torronteras R, Castaño JP, Ruiz-Navarro A, Gracia-Navarro F 1993 Application of a Percoll density gradient to separate and enrich porcine pituitary cell types. J Neuroendocrinol 5:257–266[CrossRef][Medline]
26. Castaño JP, Torronteras R, Ramírez JL, Gribouval A, Sánchez-Hormigo A, Ruiz-Navarro A, Gracia-Navarro F 1996 Somatostatin increases growth hormone (GH) secretion in a subpopulation of porcine somatotropes: evidence for functional and morphological heterogeneity among porcine GH-producing cells. Endocrinology 137:129–136[Abstract]
27. Castaño JP, Ruiz-Navarro A, Malagón MM, Hidalgo-Díaz C, Gracia-Navarro F 1997 Secretory and morphological heterogeneity of porcine somatotropes during postnatal development. J Neuroendocrinol 9:769–775[CrossRef][Medline]
28. Wu D, Chen C, Zhang J, Bowers CY, Clarke IJ 1996 The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs. J Endocrinol 148:197–205[Abstract/Free Full Text]
29. Smallrigde RC, Kiang JG, Gist ID, Fein HG, Galloway RJ 1992 U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effect in GH₃ rat pituitary cells. Endocrinology 131:1883–1888[Abstract/Free Full Text]
30. Wang XD, Kiang JG, Smallridge RC 1994 A phospholipase C inhibitor, U-73122, blocks TSH-induced inositol trisphosphate production, Ca²⁺ increase and arachidonic acid release in FRTL-5 thyroid cells. Biochim Biophys Acta 1223:101–106[Medline]
31. Roudbaraki MM, Drouhault R, Bacquart T, Vacher P 1996 Arachidonic acid-induced hormone release in somatotropes: involvement of calcium. Neuroendocrinology 63:244–256[Medline]
32. Nelson EJ, Li CCR, Bangalore R, Benson T, Kass RS, Hinkle PM 1994 Inhibition of L-type calcium-channel activity by thapsigargin and 2,5,-t-butyl-hydroquinone, but not by cyclopiazonic acid. Biochem J 302:147–154
33. Ramírez JL, Torronteras R, Castaño JP, Sánchez-Hormigo A, Garrido JC, García-Navarro S, Gracia-Navarro F 1997 Somatostatin plays a dual, stimulatory/inhibitory role in the control of growth hormone secretion by two somatotrope subpopulations from porcine pituitary. J Neuroendocrinol 9:841–848[CrossRef][Medline]
34. Takei T, Takano K, Yasufuku-Takano J, Fujita T, Yamashita N 1996 Enhancement of Ca²⁺ currents by GHRH and its relation to PKA and [Ca²⁺]_i in human GH-secreting adenoma cells. Am J Physiol 271:E801–E807
35. Martínez-Fuentes AJ, Castaño JP, Malagón MM, Vázquez-Martínez R, Gracia-Navarro F 1998 Pituitary adenylate cyclase-activating polypeptides 38 and 27 increase cytosolic free Ca²⁺ concentration in porcine somatotropes through common and distinct mechanisms. Cell Calcium 23:369–378[CrossRef][Medline]
36. Ämmälä C, Ashcroft FM, Rorsman P 1993 Calcium-independent potentiation of insulin release by cyclic AMP in single ß-cells. Nature 363:356–358[CrossRef][Medline]
37. Renström E, Eliasson L, Rorsman P 1997 Protein kinase A-dependent and -independent stimulation of exocytosis by cyclic AMP in mouse pancreatic ß-cells. J Physiol 502:105–118[Abstract/Free Full Text]
38. Dobado-Berrios PM, Ruiz-Navarro A, Almadén Y, Malagón MM, Garrido JC, Ramírez-Gutiérrez JL, Gracia-Navarro F 1996 Heterogeneity of growth hormone (GH)-producing cells in aging male rats: ultrastructure and GH gene expression in somatotrope subpopulations. Mol Cell Endocrinol 118:181–191[CrossRef][Medline]
39. Hsiung HM, Smith DP, Zhang XY, Bennett T, Rosteck Jr PR, Lai MH 1993 Structure and functional expression of a complementary DNA for porcine growth hormone-releasing hormone receptor. Neuropeptides 25:1–10[CrossRef][Medline]
40. Smith DP, Zhang XY, Frolik CA, Harvey A, Chandrasekhar S, Black EC, Hsiung HM 1996 Structure and functional expression of a complementary DNA for porcine parathyroid hormone/parathyroid hormone-related peptide receptor. Biochim Biophys Acta 1307:339–347[Medline]
41. Clapham DE, Neer EJ 1997 G protein ß subunits. Annu Rev Pharmacol Toxicol 37:167–203[CrossRef][Medline]
42. Sternweis PC, Smrcka AV 1993 G proteins in signal transduction: the regulation of phospholipase C. Ciba Found Symp 176:96–106[Medline]
43. Camps M, Carozzi A, Schnabel P, Scheer A, Parker PJ, Gierschik P 1992 Isozyme-selective stimulation of phospholipase C-ß2 by G protein ß-subunits. Nature 360:684–686[CrossRef][Medline]

This article has been cited by other articles:

				F. Rodriguez-Pacheco, R. Vazquez-Martinez, A. J. Martinez-Fuentes, M. R. Pulido, M. D. Gahete, H. Vaudry, F. Gracia-Navarro, C. Dieguez, J. P. Castano, and M. M. Malagon Resistin Regulates Pituitary Somatotrope Cell Function through the Activation of Multiple Signaling Pathways Endocrinology, October 1, 2009; 150(10): 4643 - 4652. [Abstract] [Full Text] [PDF]

				R. D. Kineman and R. M. Luque Evidence that Ghrelin Is as Potent as Growth Hormone (GH)-Releasing Hormone (GHRH) in Releasing GH from Primary Pituitary Cell Cultures of a Nonhuman Primate (Papio anubis), Acting through Intracellular Signaling Pathways Distinct from GHRH Endocrinology, September 1, 2007; 148(9): 4440 - 4449. [Abstract] [Full Text] [PDF]

				J. Rotllant, P. M. Guerreiro, L. Anjos, B. Redruello, A. V. M. Canario, and D. M. Power Stimulation of Cortisol Release by the N Terminus of Teleost Parathyroid Hormone-Related Protein in Interrenal Cells in Vitro Endocrinology, January 1, 2005; 146(1): 71 - 76. [Abstract] [Full Text] [PDF]

				R. M. Luque, R. D. Kineman, S. Park, X.-D. Peng, F. Gracia-Navarro, J. P. Castano, and M. M. Malagon Homologous and Heterologous Regulation of Pituitary Receptors for Ghrelin and Growth Hormone-Releasing Hormone Endocrinology, July 1, 2004; 145(7): 3182 - 3189. [Abstract] [Full Text] [PDF]

				M. M. Malagon, R. M. Luque, E. Ruiz-Guerrero, F. Rodriguez-Pacheco, S. Garcia-Navarro, F. F. Casanueva, F. Gracia-Navarro, and J. P. Castano Intracellular Signaling Mechanisms Mediating Ghrelin-Stimulated Growth Hormone Release in Somatotropes Endocrinology, December 1, 2003; 144(12): 5372 - 5380. [Abstract] [Full Text] [PDF]

				K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker International Union of Pharmacology. XXXV. The Glucagon Receptor Family Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194. [Abstract] [Full Text] [PDF]

				J. L. Ramirez, F. Gracia-Navarro, S. Garcia-Navarro, R. Torronteras, M. M. Malagon, and J. P. Castano Somatostatin Stimulates GH Secretion in Two Porcine Somatotrope Subpopulations through a cAMP-Dependent Pathway Endocrinology, March 1, 2002; 143(3): 889 - 897. [Abstract] [Full Text] [PDF]

				K. Venkatesh, G. Siddhartha, R. Joshi, S. Patel, and G. Hasan Interactions Between the Inositol 1,4,5-Trisphosphate and Cyclic AMP Signaling Pathways Regulate Larval Molting in Drosophila Genetics, May 1, 2001; 158(1): 309 - 318. [Abstract] [Full Text]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ramírez, J. L. Articles by Gracia-Navarro, F. Search for Related Content PubMed PubMed Citation Articles by Ramírez, J. L. Articles by Gracia-Navarro, F.